EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery

Matteo Lucchelli iD, Davide Tommaso Andreis, Mattia Gomarasca, Giovanni Mistraletti

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31744 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Matteo Lucchelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: S.C. Rianimazione E Anestesia Legnano, ASST Ovest Milanese, Legnano, Italy. Hauptthemen laut MEDLINE: Vasoplegia, Angiotensin II, Vasoconstrictor Agents, Cardiopulmonary Bypass. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing) and endothelial dysfunction due to loss of pulsatile flow. Preoperative use of angiotensin‐converting enzyme inhibitors and beta‐blockers, coronary surgery and longer duration of CPB increase the incidence of VS. VS is characterized by hypotension with high cardiac output and low systemic resistance; treatment includes fluid resuscitation and vasopressors. Current authors report a case of cardiac VS, unresponsive to conventional therapy and successfully treated with angiotensin II (ATII) and hemoadsorption therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VasoplegiaAngiotensin IIVasoconstrictor AgentsCardiopulmonary BypassCardiac Surgical ProceduresHumansTreatment OutcomeMaleSeverity of Illness IndexAgedMiddle Aged

Substanzen

Angiotensin IIVasoconstrictor Agents

Autor:innen und Institutionen

  • S.C. Rianimazione E Anestesia Legnano, ASST Ovest Milanese, Legnano, Italy.
  • Dipartimento Di Fisiopatologia Medico-Chirurgica E Dei Trapianti, Università Degli Studi Di Milano, Milano, Italy.

ORCID-Profile: Matteo Lucchelli

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Lucchelli, M., Andreis, D. T., Gomarasca, M., & Mistraletti, G. (2025). Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31744

Vancouver

Lucchelli M, Andreis DT, Gomarasca M, Mistraletti G. Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31744

BibTeX
@article{Lucchelli2025,
  author = {Lucchelli, Matteo and Andreis, Davide Tommaso and Gomarasca, Mattia and Mistraletti, Giovanni},
  title = {Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31744}
}
Kostenlos starten →